Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium fluoride is an inorganic compound used primarily for the prevention and control of dental caries (tooth decay) and for the maintenance of dental health. It is available in oral and topical forms including tablets, lozenges, solutions/drops, gels/pastes/dentifrices. Sodium fluoride acts by increasing tooth resistance to acid dissolution through remineralization of enamel and by inhibiting cariogenic bacterial processes. Its mechanism involves interfering with bacterial metabolism (notably Streptococcus mutans and lactobacilli), inhibiting glycolytic enzymes involved in lactic acid production that leads to tooth decay. Fluoride ions also alter cell membrane permeability in bacteria and lower cytoplasmic pH. Systemically (before tooth eruption), it incorporates into developing teeth; topically (post-eruption), it strengthens existing enamel[1][5][8]. Excessive exposure during development can cause fluorosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium fluoride.